Ed Conway, MD is Professor of Medicine at the University of British Columbia (UBC) in Vancouver. He holds degrees in Electrical Engineering and Medicine from the University of Toronto. Ed completed his clinical and research fellowships in Hematology-Oncology at Harvard University (Beth Israel Deaconess Medical Center) and MIT before returning to Toronto as a physician-scientist, establishing a research group in vascular biology, focusing on delineating the structure-function and regulation of thrombomodulin. In 1995, Ed moved to KU Leuven and the Flanders Institute for Biotechnology (VIB) in Belgium, where he joined the faculty of the Vesalius Research Center. There, he developed transgenic small animal models to study vascular responses to developmental, inflammatory and thrombotic stresses. He was repatriated to Canada in 2009 in the division of Hematology and the Centre for Blood Research at UBC, where his lab continues efforts to delineate mechanisms underlying the links between coagulation, innate immunity, inflammation, and cell proliferation, using small animal models in conjunction with human studies. He holds a Canada Research Chair in Endothelial Cell Biology and is supported by grants from the Heart and Stroke Foundation, the Canadian Institutes of Health Research, NSERC, CanVECTOR and Mitacs.